Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings
AUM
$28.4B
1-Year Return
37.22%
This Quarter Return
+1.73%
1 Year Return
+37.22%
3 Year Return
+93.7%
5 Year Return
+199.54%
10 Year Return
+398.51%
AUM
$22.9B
AUM Growth
+$801M
(+3.6%)
Cap. Flow
+$1.18B
Cap. Flow
% of AUM
5.13%
Top 10 Holdings %
Top 10 Hldgs %
26.16%
Holding
1,655
New
269
Increased
651
Reduced
446
Closed
272
Top Buys
| 1 |
Franco-Nevada
FNV
|
$178M |
| 2 |
TC Energy
TRP
|
$106M |
| 3 |
Pan American Silver
PAAS
|
$87.6M |
| 4 |
Waste Connections
WCN
|
$80.5M |
| 5 |
Fortis
FTS
|
$76.7M |
Top Sells
| 1 |
SAP
SAP
|
$105M |
| 2 |
Brookfield Asset Management
BAM
|
$87.6M |
| 3 |
Scotiabank
BNS
|
$84.1M |
| 4 |
Canadian Natural Resources
CNQ
|
$83M |
| 5 |
Celestica
CLS
|
$82.8M |
Sector Composition
| 1 | Financials | 23.75% |
| 2 | Technology | 17.72% |
| 3 | Industrials | 12.63% |
| 4 | Energy | 11.54% |
| 5 | Materials | 11.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Nucor
NUE
$33.3B
| $16.5M | 0.07% |
137,080
+101,518
| +285% | +$12.2M |
|
227
Jazz Pharmaceuticals
JAZZ
$7.77B
| $16.4M | 0.07% |
132,415
+20,360
| +18% | +$2.53M |
|
|
BPMC
228
DELISTED
Blueprint Medicines
BPMC
| $16.3M | 0.07% |
183,947
+41,230
| +29% | +$3.65M |
|
229
O'Reilly Automotive
ORLY
$89.1B
| $16.1M | 0.07% |
168,630
+57,990
| +52% | +$5.54M |
|
230
Mirum Pharmaceuticals
MIRM
$3.73B
| $16.1M | 0.07% |
356,276
+179,316
| +101% | +$8.08M |
|
231
Omnicell
OMCL
$1.52B
| $15.9M | 0.07% |
453,988
+24,301
| +6% | +$850K |
|
232
T Rowe Price
TROW
$24.5B
| $15.9M | 0.07% |
172,709
+144,187
| +506% | +$13.2M |
|
233
Enphase Energy
ENPH
$4.78B
| $15.8M | 0.07% |
254,672
+177,151
| +229% | +$11M |
|
234
Openlane
KAR
$3.1B
| $15.7M | 0.07% |
813,406
+126,683
| +18% | +$2.44M |
|
235
NETSCOUT
NTCT
$1.8B
| $15.7M | 0.07% |
745,459
+146,848
| +25% | +$3.09M |
|
236
Sarepta Therapeutics
SRPT
$1.93B
| $15.6M | 0.07% |
244,769
+97,533
| +66% | +$6.22M |
|
237
Eldorado Gold
EGO
$5.12B
| $15.6M | 0.07% |
928,596
-33,804
| -4% | -$568K |
|
|
SKE
238
Skeena Resources
SKE
$1.93B
| $15.4M | 0.07% |
1,524,038
+367,300
| +32% | +$3.7M |
|
239
Costco
COST
$424B
| $15.4M | 0.07% |
16,249
-35,292
| -68% | -$33.4M |
|
240
Gen Digital
GEN
$18.2B
| $15.4M | 0.07% |
578,752
+248,018
| +75% | +$6.58M |
|
241
Lumen
LUMN
$5.1B
| $15.1M | 0.07% |
3,856,417
-173,521
| -4% | -$680K |
|
242
Target
TGT
$42.1B
| $15M | 0.07% |
+144,157
| New | +$15M |
|
243
ResMed
RMD
$40.1B
| $15M | 0.07% |
67,106
+5,166
| +8% | +$1.16M |
|
244
Expedia Group
EXPE
$26.8B
| $14.8M | 0.06% |
+88,007
| New | +$14.8M |
|
245
Halliburton
HAL
$19.2B
| $14.7M | 0.06% |
577,685
+292,748
| +103% | +$7.43M |
|
246
Viking Therapeutics
VKTX
$2.98B
| $14.4M | 0.06% |
597,515
+222,293
| +59% | +$5.37M |
|
247
Hess Midstream
HESM
$5.41B
| $14.4M | 0.06% |
340,828
-62,087
| -15% | -$2.63M |
|
248
Allegion
ALLE
$14.7B
| $14.3M | 0.06% |
109,390
+20,618
| +23% | +$2.69M |
|
249
Haemonetics
HAE
$2.61B
| $14.3M | 0.06% |
224,372
-27,770
| -11% | -$1.76M |
|
|
CGAU
250
Centerra Gold
CGAU
$1.69B
| $14.2M | 0.06% |
2,244,737
-265,200
| -11% | -$1.68M |
|